Emerging Role of Fluorodeoxyglucose-PET in the Diagnosis of Cardiac Sarcoidosis.
Some studies have reported that cardiac sarcoidosis may be responsible for 13% to 25% deaths in patients with systemic sarcoidosis. In the United States the lifetime risk of sarcoidosis is estimated to be 2.4% in blacks and 0.85% in whites. This risk is higher outside the United States, with high incidence in Scandinavia, Ireland, and Japan. Cardiac involvement is more common in the Japanese population, especially in older women. This article discusses the role of cardiac images in the diagnosis of cardiac sarcoidosis, with an emphasis on cardiac fluorodeoxyglucose positron emission tomography.